Jeanette Erdmann is invited to give a talk about “What have we learnt for coronary artery disease?” at the 2021 BCS Virtual Annual Conference held June 7-10, 2021.
Due to the ongoing COVID-19 pandemic this conference will be virtual. Faculty talks will be pre-recorded and the session Q&A’s will be live, taking place during the event.
More details can be found here: https://cutt.ly/JbkNZ5Z
Jeanette Erdmann is invited to give a talk about “AI in genetics” at the Artificial Intelligence in Cardiovascular Disease meeting held May 26th-27th, 2021.
Due to the pandemic this meeting is planned as a hybrid meeting with live broadcasting.
Joining is possible either at the Cavendish Conference Centre in London or virtually.
More details can be found here: https://cutt.ly/2bkVgMV
Jeanette Erdmann is invited to give a talk about “Von der Genetik zur personalisierten Medizin” at the DGK meeting 2021 held 7. Apr. 2021 08:25.
Due to the ongoing COVID-19 pandemic this talk will be virtual.
More details can be found here: https://cutt.ly/3bk10mw
Jeanette Erdmann is invited to give a talk about “DNA, RNA, Proteine – im Dschungel der Sequenzierungsmethoden” at the Young DGK #Science meeting held April 29, 2021 from 3:00-5:00 pm.
Due to the pandemic this meeting is online-only.
More details can be found here: https://cutt.ly/rbkBY0c
The Junior Members of the Society for Biochemistry and Molecular Biology (GBM), are organizing a lecture series on “Rare Diseases” in January and February 2021.
The Junior GBM are a small group of Molecular Life Science students who, since their foundation in 2013, have been organizing both internal and public events that are part of their interests in a scientific context and allow them to gain access to current research projects alongside their studies.
On October 6th, 2020 at 9:00 am Anja Trillhaase will defend her PhD thesis “Impact of the CAD risk locus 9p21 on vascular calcification – development of an iPSC-based model”.
We are looking forward to a great talk, vivid discussions, and an impressive Q&A session.
Happy to share that on September 23th 2020 from 15:30-15:45 Anja Trillhaase is going to present her work entitled “The influence of the 9p21 CAD risk locus on vascular calcification – an iPSC model” at the 8th Annual German Stem Cell Network (GSCN) Conference (Abstract T04 in session: Stem cells in disease modeling and drug development).
On Friday, September 4th, 2020 from 6:00 – 7:00 pm, Jeanette Erdmann and Thorsten Kessler (DHM, Munich) will talk about cardiovascular genetics at the “Cardiometabolism Virtual Seminar”. Please join us using Zoom ID 692-600-595.
Jeanette Erdmann, Cardiovascular genetics: Past, Present, Future
Thorsten Kessler, Insights from the GUCY1A1 coronary artery disease locus
On November 27, 2019 at 3 pm in the seminar room EG (MFC1) the guest lecture given by Valerie Allamand will take place.
You are happily invited!
Valerie Allamand, PhD
Lund University & Research Center of Myology Inserm Paris, France
“Collagen VI-deficiency and its consequences on the myomatrix”
November 27, 2019, 3 p.m., Seminar Room EC (MFC1)
Valerie Allamand is a group leader at UMR S974-Institut de Myologie, Paris (France). Currently, she is working at Lund University as a visiting research fellow. Valerie Allamand studies the physiopathology and therapeutic approaches for ColVI-related myopathies.
Collagen VI-related myopathy is a group of disorders that affect skeletal muscles and connective tissue. Most affected individuals have muscle weakness and joint deformities called contractures that restrict movement of the affected joints and worsen over time. Researchers have described several forms of collagen VI-related myopathy, which range in severity: Bethlem myopathy is the mildest, an intermediate form is moderate in severity, and Ullrich congenital muscular dystrophy is the most severe. Currently, no cure is available.
On Sunday April 7th we will welcome our colleagues and collaborators from the PlaqOmics consortium for a two-days progress meeting.
PlaqOmics is funded by the Leducq Foundation for a total of 5 years. We started in Autumn 2018 and we have next week our first progress meeting.
40 scientists, from senior to junior researcher, will discuss our hypothesis that detrimental reprogramming of smooth muscle cells (SMC) destabilizes atherosclerotic plaques and that there are critical genetic determinants of coronary artery disease risk that act in part by impacting SMC phenotypic transitions.
More information about PlaqOmics can be found here: www.plaqomics.com
